PG01
An Australian Pilot Preceptorship Program for Multiple Sclerosis Nurses and Study Coordinators.
The care and management of Multiple Sclerosis (MS) varies widely across Australia. MS Nurses may work in isolation, part of a small team or within a tertiary hospital. Consequently, the scope and delivery of clinical care, capacity for involvement in clinical research, level of support and opportunities for education and mentoring are significantly different across Australia. The past few years have seen a dramatic expansion of MS treatments, with twelve treatments now available first-line. This creates challenges for sites in managing complex treatment decisions, drug administration and long-term safety monitoring. Similarly, clinical trials are becoming increasingly complex and logistically challenging, making it important for Australian sites to have the tools and expertise to contribute to quality data.
Austin Health’s Neuroimmunology, Clinical Research, Education and Support Service (N-CRESS) is one of the leading MS care facilities in Australia. We are committed to ongoing professional development and continuous quality improvement that leads to better patient outcomes. N-CRESS recognises the reciprocal value of peer-assisted learning, and as a larger centre of excellence in MS clinical and research care, we commenced a pilot Preceptorship Program (PPP). With logistical and financial support from Novartis Pharmaceuticals we invited external nurses and study coordinators to observe our centre at work, share information and establish linkages for ongoing mentorship, collaboration and communication.
Objectives:
To assess the PPP via participant feedback.
Methods:
The PPP offered participants a Clinical MS Nursing focus and/or a Clinical Research educational focus. Before commencing, a Needs Assessment Questionnaire was completed to ensure N-CRESS could provide the appropriate educational opportunities. An Appraisal Form was completed after participation.
Results:
Twelve participants completed the program. Three focused on Clinical, five on Research and four on both. All participants completed the appraisal form, which included eight questions about content, value and utility. Feedback was very positive.
Conclusions:
The PPP was judged worthwhile and will be continued. Participants particularly valued the active learning opportunities provided and the sharing of knowledge and tools to lead to better outcomes for people with MS. We recommend the implementation of this program in other regions to enhance MS Nurse professional development.